% | $
Quotes you view appear here for quick access.

Eli Lilly and Company Message Board

  • pharmaheroib pharmaheroib Jul 29, 2011 8:42 AM Flag

    (ot) Awaiting 5 FDA approvals (Mcap 57 M )Low Float 2 MIL


    This Unknown ULTRA LOW FLOAT Stock awaiting 5 FDA approvals and will rise to 7 by year end .IPCI has 15 Drugs in Pipeline many nearing ANDA/NDA filing including a potential Blockbuster .

    Market Cap 57 Mil / Cash 8.5 M / Burn-rate 4.5 M per Year = Enough Cash until Profitability which will happen in 2012

    First FDA approval and PartnerShip which is imminent will push this low float rocket into double digits easily ..GLTA

    Intellipharmaceutics (IPCI)

    Market Cap: 57 M
    Cash: 8.5 M
    Price: 3.71 $

    Shares Out: 15.9 Mil..(13 Mil Shares held by Insiders/Institutions)
    Low Float : 2 M

    Intellipharmaceutics now has five ANDAs awaiting FDA approval with reported sales for branded and generic versions of these products being approximately $8 billion in 2010. The Company develops both ANDA product candidates and new drugs through the New Drug Application (NDA) 505(b)(2) regulatory pathway.

    "The filing of a generic version of Seroquel XR® is one of the Company's performance milestones for 2011 and another important addition to our product portfolio filed for approval with the FDA, which includes generics of Focalin XR®, Effexor XR®, Protonix® DR and Glucophage® XR," commented Dr. Isa Odidi, CEO of Intellipharmaceutics. "These filings not only provide further validation of our Hypermatrix™ technology, they clearly demonstrate the flexibility of our technology to efficiently and effectively match a number of drug delivery profiles."


71.27-0.15(-0.21%)Feb 12 4:02 PMEST